Butterfly Network currently boasts the world’s largest installed base of point-of-care ultrasound (POCUS) devices, with its ...

Lake Street analyst Ben Haynor raised the firm’s price target on Butterfly Network (BFLY) to $5.50 from $4 and keeps a Buy rating on the shares. The firm, which expects investors both inside and ...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today ...

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE ...

The average one-year price target for Butterfly Network, Inc. - Equity Warrant (NYSE:BFLY.WS) has been revised to $0.01 / ...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ...

With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology. The bundled ...

CEO Joseph DeVivo highlighted the company’s 20% revenue growth and improved gross margins of 63% for the quarter. He emphasized the diversification of the product portfolio, including two generations ...

Butterfly Network's innovative portable ultrasound devices show strong disruption potential. Despite promising technology and international expansion, the company faces significant cash burn and ...

Artificial intelligence-powered operating system built for compliant, scalable, revenue-ready POCUS programs. Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health ...

Results highlight the role of artificial intelligence development in enabling earlier detection of aortic stenosis. “This research shows a promising path forward where lower-level providers, not just ...

Aortic stenosis, a narrowing of the aortic valve, affects over 13% of Americans over 75 years old and is often missed until it’s advanced and symptomatic. Studies(1, 2) suggest that a significant ...